Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs)
$104.24
pos +2.06
+2.02%
Today's Range: 102.45 - 104.68 | AMGN Avg Daily Volume: 4,346,500
Last Update: 05/21/13 - 4:00 PM EDT
Volume: 3,487,807
YTD Performance: 22.54%
Open: $102.45
Previous Close: $102.18
52 Week Range: $67.61 - $114.95
Oustanding Shares: 749,976,556
Market Cap: 79,220,023,610
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 12 12 12
Moderate Buy 0 0 1 1
Hold 13 13 13 13
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.13 2.04 2.04 2.04
Latest Dividend: 0.47
Latest Dividend Yield: 1.78%
Dividend Ex-Date: 05/14/13
Price Earnings Ratio: 17.84
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
17.84 17.90 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
26.34% 44.85% 92.72%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.80 0.18 0.06
Net Income 0.00 0.00 0.00
EPS 36.60 0.24 0.07
Earnings for AMGN:
EBITDA 6.96B
Revenue 17.27B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $1.68 $1.73 $7.19 $8.31
Number of Analysts 4 4 4 4
High Estimate $1.71 $1.80 $7.25 $8.74
Low Estimate $1.65 $1.70 $7.16 $7.80
Prior Year $1.82 $1.67 $6.45 $7.19
Growth Rate (Year over Year) -7.83% 3.44% 11.51% 15.47%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
JOHNDHasseyJr
JOHNDHasseyJr: RT @NASDAQ: NASDAQ-100 AHI at 2982.57 (up 0.02%) movers: $FFIV, $DTV, $NVDA, $AMGN, $FB http://t.co/3xWOe5qVgh #nasdaq
2 hours ago from Twitter for iPhone
SwingTradeAlert
SwingTradeAlert: $AMGN Regaining key support + 50DMA Looks good here. http://t.co/mZX9o28kgv
2 hours ago from StockTwits Web
tradingview
tradingview: $AMGN chart by beanz744: http://t.co/gyuZd5hiod Need another couple bars to see.
2 hours ago from TradingView
DozenStocks
DozenStocks: Top S&P100 #Stocks Performance $MDT $MRK $HD $AMGN $CMCSA $JPM $GILD $COST $WFC $GS $FDX $AXP $CVX $CVS more@ http://t.co/n4QZIDxy7w
5 hours ago from CJ AutoTweeter
DozenStocks
DozenStocks: Top Nasdaq100 #Stocks Performance $SHLD $NUAN $CHRW $BIIB $VRTX $ALXN $ATVI $WDC $AMGN $AVGO $FAST $BBBY more@ http://t.co/YdSIjG11yN
5 hours ago from CJ AutoTweeter
DozenStocks
DozenStocks: Top S&P500 #Stocks Performance $MDT $MRK $AZO $TDC $CHRW $BIIB $CVC $ALXN $HD $ACT $KSS $WDC $NUE $AMGN more@ http://t.co/RPeaHBZz9y
5 hours ago from CJ AutoTweeter
StockPlayer6
StockPlayer6: RT @CAMAR024: $XLV decent flag setup. like $BIIB for continuation and $AMGN for a bounce….$GILD could rip to 60
6 hours ago from web
CAMAR024
CAMAR024: $XLV decent flag setup. like $BIIB for continuation and $AMGN for a bounce….$GILD could rip to 60
6 hours ago from Twitter for Mac
stockchartscom
stockchartscom: Today's Top 5 Technical Gainers among S&P Stocks: $AZO, $MDT, $HD, $AMGN, $TE http://t.co/ctFzkw6tom #sccrankings #stockcharts
10 hours ago from StockCharts.com
HumbleBioTrader
HumbleBioTrader: RT @TraderInPlay: Pharma a top-performing $SPX sector on the day: $XLV $MRK $GILD $AMGN $BIIB
10 hours ago from web

Tackling the Rotation Dilemma

By

Jim Cramer

| May 07, 2013 | 6:53 AM EDT
I have always resolved it in a practical, but chicken, way.

Early-Morning Market Look Real Money Pro($)

By

Doug Kass

| May 01, 2013 | 7:37 AM EDT
Let's take a peek and overnight and morning markets.
Bullish
Amgen upgraded at Goldman
May 01, 2013 | 7:29 AM EDT
AMGN was upgraded from Neutral to Buy, Goldman Sachs said. $130 price target. Company also added to the Conviction Buy List, as the com...

All the Reasons in the World to Pull Back

By

Helene Meisler

| Apr 28, 2013 | 7:00 PM EDT
Yet the market refuses -- and sentiment is anything but giddy, even at these heights.

Off the Charts Real Money Pro($)

By

Scott Redler

| Apr 24, 2013 | 6:50 PM EDT
Banks continued higher, basic materials outperformed.

National Lemming Day

By

Jim Cramer

| Apr 24, 2013 | 1:16 PM EDT
It’s the only thing that explains today’s action.

From the Street of Dreams Real Money Pro($)

By

Doug Kass

| Apr 24, 2013 | 7:46 AM EDT
Here is what the analyst community is up to this morning.
Bullish
Amgen estimates increased at UBS
Apr 24, 2013 | 7:41 AM EDT
AMGN estimates were raised on improving operating expenses, despite the weak first quarter results, said UBS.

Early-Morning Market Look Real Money Pro($)

By

Doug Kass

| Apr 24, 2013 | 7:21 AM EDT
Let's take a peek at the markets.

For Apple Heads Real Money Pro($)

By

Doug Kass

| Apr 23, 2013 | 4:59 PM EDT
It guides to a very weak third quarter.

Columnist Conversation / Market Updates

NetApp (NTAP): Storing Up Disappointment
By Chris Laudani
| May 21, 2013
| 5:33 PM EDT
Co misses on revenues. Revenue rose (if you can call it that) 0.8% to $1.7 bin. (I was looking for 1.7% y/y rev growth.)...
Making a late move on NTAP
By Robert Lang
| May 21, 2013
| 3:46 PM EDT
We added a call spread for NTAP here, not as pricey as the move implies, the chart not looking too bad. I like this for...
See all »

Our Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.